The goal of this activity is to educate health care professionals about current issues related to type 2 diabetes. This education will provide an overview and differentiation of currently available GLP-1 RAs to manage this disease, including mechanism of action, dosing optimization and administration, glycemic and extra-glycemic effects, safety and tolerability concerns, and early place in therapy according to treatment guidelines.